New Developments with Sterile Disposable Technology and Single-Use Systems for Aseptic Processing
Posted on September 27, 2018
Tim Sandle
Head of Microbiology
BPL
Introduction Pharmaceutical drug products are produced to be efficacious; however the presence of microorganisms or microbial by-products in these products may have adverse effects on their efficacy. Contamination of aseptically filled biotechnological products is costly and it can pose serious harm...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
BPL, microbial by-products, microorganisms, Sterile Disposable Technology, sterility assurance, Tim Sandle
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
